Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
HIV extended learning activity
You are the clinical pharmacist working at the HIV clinic. Today Peter presents at the clinic complaining of severe muscle aches, lethargy and generally feeling terrible.
Mandatory reporting: New reporting rules give advance warning
On 1 January 2019, new laws will enforce the mandatory reporting scheme for medicine shortages – a welcome change.
It’s a very difficult conversation...
Digital Health CRC to put focus on future of pharmacy
Pharmacists are being encouraged to look at the potential benefits digital technology will bring to the profession in the coming years.
Professor Libby Roughead, from...
Taking care: the different areas of medicine safety
In its landmark Medicine Safety: Take Care report, PSA identified the frightening cost of medicine misadventure in Australia. With medicines safety a central theme...
ACT politicians commit to supporting pharmacists
Pharmacist vaccinators in the ACT should be given greater scope to protect their communities against infectious diseases, PSA has argued.
Pharmacists in GP surgeries: the UK perspective
The workforce issue facing general practice has been around for some time in the United Kingdom. Between 2007 and 2014, the GP clinical workload...
